AbbVie
ABBV
1,652 hedge funds and large institutions have $80.2B invested in AbbVie in 2015 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 681 increasing their positions, 636 reducing their positions, and 57 closing their positions.
116% more first-time investments, than exits
New positions opened: 123 | Existing positions closed: 57
75% more funds holding in top 10
Funds holding in top 10: 81 → 142 (+61)
23% more capital invested
Capital invested by funds: $65.3B → $80.2B (+$14.9B)
23% more call options, than puts
Call options by funds: $1.49B | Put options by funds: $1.21B
5.39% more ownership
Funds ownership: 69.98% → 75.37% (+5.4%)
3% more funds holding
Funds holding: 1,600 → 1,652 (+52)
7% more repeat investments, than reductions
Existing positions increased: 681 | Existing positions reduced: 636
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.95B |
| 2 |
GCM
Glenview Capital Management
New York
|
+$1.01B |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$938M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$660M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$561M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$489M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$294M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$259M |
| 4 |
Capital International Investors
Los Angeles,
California
|
-$241M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$213M |
ABBV Hedge Fund Activity: Q2 2015 in Review
1,652 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in AbbVie (ABBV) for Q2 2015, worth a combined $80.2B — up 23% from $65.3B a quarter earlier.
Buyers outnumbered sellers: 123 funds opened new ABBV positions and 57 closed out — a net gain of 66 holders — while 681 added to existing stakes and 636 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.95B. The largest seller was Capital Research Global Investors, cutting an estimated $489M.
- 1,652 institutional investors held AbbVie (ABBV) as of Q2 2015, up from 1,600 in Q1 2015.
- Funds reported $80.2B of AbbVie stock for Q2 2015, up 23% quarter-over-quarter.
- 123 funds opened new AbbVie positions in Q2 2015 and 57 closed out, a net change of +66 holders.
- The largest AbbVie buyer in Q2 2015 was Morgan Stanley, an estimated $1.95B added.
- The largest AbbVie seller in Q2 2015 was Capital Research Global Investors, an estimated $489M sold.
Based on aggregated 13F filings for Q2 2015.